There are errors in the Funding statement. The correct Funding statement is as follows: The current study is funded by Iran National Science Foundation with grant ID 940007 and 95824986 to Sima Rafati. Also Farnaz Zahedifard received funding from Pasteur Institute of Iran as part of her Ph.D studentship. She also got Calmette and Yersin training scholarship from RIIP foundation from Institut Pasteur International Network for her training period in South Korea. The founders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Reference
- 1. Zahedifard F, Lee H, No JH, Salimi M, Seyed N, Asoodeh A, et al. (2019) Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials. PLoS Negl Trop Dis 13(2): e0007217. https://doi.org/10.1371/journal.pntd.0007217 pmid:30811391
Citation: Zahedifard F, Lee H, No JH, Salimi M, Seyed N, Asoodeh A, et al. (2019) Correction: Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials. PLoS Negl Trop Dis 13(7): e0007584. https://doi.org/10.1371/journal.pntd.0007584
Published: July 16, 2019
Copyright: © 2019 Zahedifard et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.